The development of in vitro protocols able to discriminate skin irritants from non-irritants integrates the toxicologists' needs for reliable and robust in vitro tools for screening test substances. Based on EpiSkin test method, validated by ESAC (ECVAM Scientific Advisory Committee) in April 2007 as the Draize skin irritation replacement reference test method, we present and discuss here the results obtained by adapting protocols to the SkinEthic Reconstructed Human Epidermis (RHE) model. The main adaptations of the validated reference protocol consists in a modulated exposure time (15, 42 or 60min) followed by a rinsing step and a 42h post-incubation period before quantitative measurement of cell viability by MTT reduction. The results obtained with a set of 39 test substances allowed to determine a prediction model with a cut-off of 50%. The best reliability was obtained with the proposed "42 bis" (42min+42h) test method. An overall accuracy of 85% was reached when testing the 20 ECVAM selected reference test substances. The performance of this optimized test method was confirmed by its higher robustness compared to other proposed protocols. As such, none of test substances showed a standard deviation above 18%. This optimized skin irritation protocol has thus been established according to the ECVAM intra-laboratory minimum performance standards.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tiv.2009.08.023 | DOI Listing |
Environ Mol Mutagen
January 2025
Department of Pharmacology and Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Ahmedabad, Gujarat, India.
The bacterial reverse mutation test is essential for identifying the mutagenic potential of chemicals. The solubility of the test substance is vital for achieving the recommended assay concentration. Preferred solvents like dimethyl sulfoxide and water are chosen for their compatibility and historical data.
View Article and Find Full Text PDFBio Protoc
January 2025
Laboratory of Protein Translation and Fungal Pathogenesis, Regional Centre for Biotechnology, Faridabad, India.
, labeled an urgent threat by the CDC, shows significant resilience to treatments and disinfectants via biofilm formation, complicating treatment/disease management. The inconsistencies in biofilm architecture observed across studies hinder the understanding of its role in pathogenesis. Our novel in vitro technique cultivates biofilms on gelatin-coated coverslips, reliably producing multilayer biofilms with extracellular polymeric substances (EPS).
View Article and Find Full Text PDFCureus
December 2024
Department of Periodontology and Implantology, Government Dental College and Hospital, Jamnagar, Jamnagar, IND.
Introduction In their routine practice, dentists frequently encounter dentinal hypersensitivity, which is caused by the pulpal nerves' increased excitability due to fluid movement in the dentinal tubules. It is treated in-office using dentin desensitizers, which reduce hypersensitivity by obstructing the open tubules or desensitizing the free nerve endings present within the tubules. However, no substance or treatment plan has ever been proven to be the gold standard for the efficient treatment of dentinal hypersensitivity.
View Article and Find Full Text PDFContemp Clin Trials Commun
February 2025
Dept. of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University, Detroit, MI, USA.
Background: In people with substance use disorders (SUDs), stress-exposure can impair executive function, and increase craving and likelihood of drug-use recurrence. Research shows that acute stressors increase drug-seeking behavior; however, mechanisms underlying this effect are incompletely understood. The Competing Neurobehavioral Decisions System theory posits that persons with SUDs may have hyperactive limbic reward circuitry and hypoactive executive control circuitry.
View Article and Find Full Text PDFDespite high rates of substance use, youth involved in the juvenile justice system are unlikely to be linked to the treatment services they need. Family Connect is a flexible, family-focused, linkage intervention developed to address multilevel barriers and increase youth engagement in care through the introduction of a linkage specialist. We describe the components of Family Connect and present findings from the intervention pilot test comparing 18 youth-caregiver dyads to 95 historical controls on referral, attending intake and initiating treatment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!